Aspen Pharmacare CEO Stephen Saad is in the C-SUITE

Aspen has demonstrated a robust performance over the six months to December 2021. The manufacture of Johnson and Johnson’s COVID-19 vaccine at the group’s South African manufacturing operation is on track for the end of the current financial year 2021